• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR Back to Search Results
Model Number G154
Device Problems Over-Sensing (1438); Low impedance (2285); Ambient Noise Problem (2877); Device Operates Differently Than Expected (2913); Device Sensing Problem (2917)
Patient Problem Complaint, Ill-Defined (2331)
Event Date 09/23/2017
Event Type  Injury  
Manufacturer Narrative
No additional information is available.If additional information becomes available, this report will be updated at that time.
 
Event Description
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) system detected an out of range atrial intrinsic amplitude measurement and an out of range atrial pacing impedance measurement of less than 200 ohms.The stored episodes were reviewed, and it was noted there were multiple atrial tachy response (atr) episodes due to inappropriate noise detection.No pacing inhibition of greater than 2 seconds noted.The root cause for the clinical observations remains undetermined.Technical services recommended an in-office check to further evaluate the device system.Additional information was received that the patient was seen in the clinic.Two episodes were reviewed, and were suggestive of ventricular tachycardia (vt).During one of the vt episodes, patient experienced tunnel vision and felt like he was going to pass out.The patient further explained it felt like when he previously had cardiac arrest.It was noted the associated right ventricular (rv) and left ventricular (lv) leads were stable.The decision was made to reprogram the atr duration, increase the atrial amplitude to 2.2 v, increase the atrial sensitivity to 1.5 mv and increase the lv amplitude to 2.9 v.The physician also changed the vt zone from 185 beats/minute to 150 beats/minute.The associated right atrial (ra) lead may be replaced at a future date.At this time, this crt-d remains in service and there were no adverse patient effects reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information was received that the associated right atrial (ra) lead was surgically abandoned and replaced due to noise, oversensing and intermittent low pacing impedances.The root cause for the clinical observations was not determined.This cardiac resynchronization therapy defibrillator (crt-d) remains in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN
Type of Device
IMPLANTABLE CHF GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7353852
MDR Text Key102972925
Report Number2124215-2018-03798
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534652
UDI-Public00802526534652
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/20/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/20/2017
Device Model NumberG154
Other Device ID NumberDYNAGEN CRT-D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received03/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/20/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0158; 4087; 4513; G154; H175; N118
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age68 YR
-
-